RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects [Yahoo! Finance]
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells [Yahoo! Finance]
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement